BIONORICA Trademark

Trademark Overview


On Thursday, March 26, 2009, a trademark application was filed for BIONORICA with the United States Patent and Trademark Office. The USPTO has given the BIONORICA trademark a serial number of 79070126. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, December 15, 2020. This trademark is owned by Bionorica AG. The BIONORICA trademark is filed in the Cosmetics & Cleaning Products, Pharmaceutical Products, and Paper & Printed Material Products categories with the following description:

Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of [ gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, ] angina, [ atherosclerosis, ] bronchial asthma, [ circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climacteric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulm...

[ Paper; cardboard; goods made from paper and cardboard, namely, paper bags, coasters, and works of art in the nature of art prints; printed matter, namely, books, magazines, journals, newspapers, periodicals, leaflets, manuals, catalogs and brochures in the fields of health and medicine; printed reviews in the nature of a series of written articles in the fields of health and medicine; bookbinding material, namely, book bindings; photographs; stationery; adhesives for stationery or household purposes; artists' materials, namely, artists' pastels, artists' pencils, artists' pens, painting sets for children; paint brushes; typewriters; office requisites except furniture, namely, punches, staplers, erasers, desk pads, pencil sharpeners; instructional and teaching material, namely, printed instructional and teaching material in the field of medicine and phytopharmacy; paper bags, envelopes and pouches for packaging, plastic bags and bubble packs for packaging ]

[ Essential oils for use in the manufacture of cosmetics, hair lotions and perfumery; hair lotions; dentifrices ]
bionorica

General Information


Serial Number79070126
Word MarkBIONORICA
Filing DateThursday, March 26, 2009
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, December 15, 2020
Registration Number3870253
Registration DateTuesday, November 2, 2010
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2010

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment, cure, mitigation or prevention of [ gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, ] angina, [ atherosclerosis, ] bronchial asthma, [ circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climacteric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, ] inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, [ arthritis, osteoarthritis, ] fever, cough, cold, [ Alzheimer's disease, ] infection of respiratory tract, [ infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, analeptic, and tranquilizer; haemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; medicinal preparations in tablet form, namely, menstruation circulation regulating tablets; pharmaceutical preparations, namely, for hormone regulation and hormone replacement; ] pharmaceutical preparations for sensory organs, namely, for use in [ ophthalmology, ] otolaryngology [ and dermatology] ; pharmaceutical preparations for regulation and strengthening of the immune system, [ pharmaceutical preparations for treating of and providing temporary relief for occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of medicated balms, medicated dental tapes, medicated dental ribbons, medicated dental polish; pharmaceutical preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; medicated mouth sprays, ] plant extracts for [ veterinary and ] pharmaceutical purposes; [ sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for health purposes; medicated sanitary preparations for the treatment, cleaning and protection of the skin; ] dietary supplements in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form, containing plant extracts; dietetic foods adapted for medical use in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form; [ food for medically restricted diets, food for diabetics, ] food supplements containing plant extracts, food supplements derived from plants or plant extracts, all aforesaid goods in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form; [ vitamin and mineral supplements; food and food supplements, namely, herbal teas for medicinal purposes and medicinal teas; nutritional additives for use in foods and dietary supplements for human consumption; ] dietetic food supplements, dietary supplements, food supplements and dietary food supplements; [ mineral food supplements, food supplements based on amino acids, minerals and/or trace elements, medical plasters; materials for dressings, namely, gauze and bandages; all purpose disinfectants, material for stopping teeth; dental wax ]
Goods and Services[ Paper; cardboard; goods made from paper and cardboard, namely, paper bags, coasters, and works of art in the nature of art prints; printed matter, namely, books, magazines, journals, newspapers, periodicals, leaflets, manuals, catalogs and brochures in the fields of health and medicine; printed reviews in the nature of a series of written articles in the fields of health and medicine; bookbinding material, namely, book bindings; photographs; stationery; adhesives for stationery or household purposes; artists' materials, namely, artists' pastels, artists' pencils, artists' pens, painting sets for children; paint brushes; typewriters; office requisites except furniture, namely, punches, staplers, erasers, desk pads, pencil sharpeners; instructional and teaching material, namely, printed instructional and teaching material in the field of medicine and phytopharmacy; paper bags, envelopes and pouches for packaging, plastic bags and bubble packs for packaging ]
Goods and Services[ Essential oils for use in the manufacture of cosmetics, hair lotions and perfumery; hair lotions; dentifrices ]

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, March 29, 2017
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 24, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, March 29, 2017
Primary Code016
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBionorica SE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNeumarkt 92318
DE

Party NameBionorica SE
Party Type21 - New Owner After Publication
Legal Entity Type98 - Unknown
AddressDE

Party NameBionorica AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address92318 Neumarkt
DE

Party NameBionorica AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address92318 Neumarkt
DE

Trademark Events


Event DateEvent Description
Tuesday, July 28, 2009APPLICATION FILING RECEIPT MAILED
Monday, August 3, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 3, 2009REFUSAL PROCESSED BY IB
Thursday, July 23, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, July 23, 2009LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Friday, July 24, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 24, 2009ASSIGNED TO EXAMINER
Friday, July 31, 2009NON-FINAL ACTION WRITTEN
Saturday, August 1, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 3, 2009REFUSAL PROCESSED BY MPU
Tuesday, March 23, 2010FAX RECEIVED
Wednesday, March 24, 2010FAX RECEIVED
Monday, January 25, 2010PAPER RECEIVED
Tuesday, February 23, 2010ASSIGNED TO LIE
Friday, February 26, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 26, 2010AMENDMENT FROM APPLICANT ENTERED
Friday, February 26, 2010REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Friday, February 26, 2010NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
Wednesday, March 24, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 26, 2010AMENDMENT FROM APPLICANT ENTERED
Saturday, May 29, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 26, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 26, 2010AMENDMENT FROM APPLICANT ENTERED
Tuesday, April 13, 2010REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Wednesday, April 14, 2010NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 12, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 28, 2010ASSIGNED TO LIE
Saturday, May 29, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 7, 2010EXAMINER'S AMENDMENT ENTERED
Monday, June 7, 2010EXAMINERS AMENDMENT -WRITTEN
Monday, June 7, 2010EXAMINERS AMENDMENT E-MAILED
Monday, June 7, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 9, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 14, 2010PRIORITY ACTION WRITTEN
Monday, June 14, 2010PRIORITY ACTION E-MAILED
Monday, June 14, 2010NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, July 9, 2010EXAMINERS AMENDMENT -WRITTEN
Friday, July 9, 2010EXAMINERS AMENDMENT E-MAILED
Friday, July 9, 2010EXAMINER'S AMENDMENT ENTERED
Friday, February 11, 2011FINAL DISPOSITION PROCESSED
Friday, February 11, 2011FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 9, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 12, 2010ASSIGNED TO LIE
Monday, July 12, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 17, 2010PUBLISHED FOR OPPOSITION
Tuesday, August 17, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, September 2, 2010CHANGE OF OWNER RECEIVED FROM IB
Tuesday, November 2, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, February 2, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, February 18, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 7, 2017PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 12, 2014NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, October 12, 2016TEAS SECTION 71 RECEIVED
Tuesday, March 28, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 29, 2017REGISTERED - PARTIAL SEC 71 ACCEPTED
Wednesday, March 29, 2017NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Wednesday, November 29, 2017PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, December 7, 2017INVALIDATION PROCESSED
Thursday, January 11, 2018PARTIAL INVALIDATION PROCESSED BY THE IB
Thursday, April 11, 2019INTERNATIONAL REGISTRATION RENEWED
Saturday, November 2, 2019COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, September 16, 2020TEAS SECTION 71 RECEIVED
Wednesday, December 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, August 15, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, December 15, 2020REGISTERED-SEC.71 ACCEPTED
Tuesday, December 15, 2020NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, February 17, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, September 1, 2021INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Saturday, April 22, 2023NEW REPRESENTATIVE AT IB RECEIVED
Saturday, May 18, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 3, 2024NEW REPRESENTATIVE AT IB RECEIVED
Saturday, September 9, 2023NEW REPRESENTATIVE AT IB RECEIVED